Bactiguard (STO:BACTIB) has received a major order from India of some 50 000 Foleys for infection prevention. At the same time, the planned clinical study has been initiated.
The first order from India consists of some 50 000 Foley catheters for infection protection (BIP Foleys) and generates direct sales revenues of close to 2 million SEK, at product delivery.
- We are delighted that we can now start penetrating the Indian market for real. The problem of healthcare associated infections is huge, particularly in India, where the largest consumption of antibiotics in the world has led to a high level of multi-resistant bacteria. This means that there is an urgent need for preventive solutions, says Cecilia Edström, Director of Sales & New Business.
The first order from India consists of some 50 000 Foley catheters for infection protection (BIP Foleys) and generates direct sales revenues of close to 2 million SEK, at product delivery.
- We are delighted that we can now start penetrating the Indian market for real. The problem of healthcare associated infections is huge, particularly in India, where the largest consumption of antibiotics in the world has led to a high level of multi-resistant bacteria. This means that there is an urgent need for preventive solutions, says Cecilia Edström, Director of Sales & New Business.
